Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children

NCT: NCT06285812 · ACTIVE_NOT_RECRUITING

NCT IDNCT06285812
StatusACTIVE_NOT_RECRUITING
Start Date2024-01-10
Completion2026-07

Brief Summary

A pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.

Frequently Asked Questions

What is Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children?

Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children is a clinical trial registered under NCT06285812. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06285812?

The current status of NCT06285812 (Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children) is: ACTIVE_NOT_RECRUITING.

When did Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children start?

Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children started on 2024-01-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑